COMPASS PATHWAYS PLC (CMPS:NASDAQ)
$13.39 0.205 (1.5548%)
Analysed COMPASS PATHWAYS PLC (CMPS:NASDAQ) News Sources
CMPS Stock Climbs After-Hours: Analyst Sees Depression Drug Approval By H1 2027 Or Sooner After Strong Trial Data
09-07-2026
stocktwits.com
Does COMPASS Pathways (CMPS) Have Upside Left Above Fair Value?
09-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise Thursday
09-07-2026
yahoo.com
3 Psychedelic Stocks With Potential Clinical Trial Catalysts
10-07-2026
yahoo.com
Compass Pathways Eyes 2027 Launch as Psilocybin Depression Data Holds Up
10-07-2026
marketbeat.com
Cathie Wood Dumps AMD, Doubles Down on Meta Stock
10-07-2026
yahoo.com
Psychedelics guidance from the FDA set to benefit developers, including AtaiBeckley, Jefferies says
13-07-2026
proactiveinvestors.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
13-07-2026
yahoo.com
The Race to Commercialize the World’s Most Powerful Psychedelic
14-07-2026
yahoo.com
Is COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?
15-07-2026
yahoo.com
What is the current price of COMPASS PATHWAYS PLC (CMPS:NASDAQ)?
The current price of COMPASS PATHWAYS PLC (CMPS:NASDAQ) is $13.39.
COMPASS PATHWAYS PLC (CMPS:NASDAQ) absolute price change since previous trading day?
The absolute price change of COMPASS PATHWAYS PLC (CMPS:NASDAQ) since the previous trading day is $0.205.
COMPASS PATHWAYS PLC (CMPS:NASDAQ) percentage price change since previous trading day?
The percentage price change of COMPASS PATHWAYS PLC (CMPS:NASDAQ) since the previous trading day is 1.5548%.
What is the most recent average sentiment score for COMPASS PATHWAYS PLC (CMPS:NASDAQ)?
The most recent average sentiment score for COMPASS PATHWAYS PLC (CMPS:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for COMPASS PATHWAYS PLC (CMPS:NASDAQ)?
The most recent sentiment for COMPASS PATHWAYS PLC (CMPS:NASDAQ) is .
SEC-8K** Filing Available For COMPASS PATHWAYS PLC (CMPS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.